Inadequate management of cerebrovascular risk factors in participants of a public stroke prevention program in Austria

European Journal of Neurology

Volumn 11, Issue 10, 2004, Pages 679-685

  Iglseder, Bernhard ^a   Moroder, T ^a   Staffen, W ^a   Ladurner, G ^a  

^a Christian Doppler Klinik   (Austria)

Author keywords

Prevention; Stroke; Treatment; Vascular risk factors

Indexed keywords

ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ANAMNESIS; ANTICOAGULATION; ARTICLE; AUSTRIA; CEREBROVASCULAR DISEASE; CIGARETTE SMOKING; DIABETES MELLITUS; DISEASE CLASSIFICATION; FOLLOW UP; HEALTH CARE QUALITY; HEALTH PROMOTION; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE HYPERTROPHY; HIGH RISK POPULATION; HUMAN; HYPERTENSION; POPULATION RISK; PRIORITY JOURNAL; PUBLIC HEALTH; RISK ASSESSMENT; RISK FACTOR; STROKE;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ATRIAL FIBRILLATION; AUSTRIA; BLOOD PRESSURE; CEREBROVASCULAR ACCIDENT; COUMARINS; DIABETES MELLITUS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PROSPECTIVE STUDIES; RISK FACTORS; SALICYLIC ACID;

EID: 6344238651     PISSN: 13515101     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2004.00912.x     Document Type: Article

References (45)

1. Albers GW (1994). Atrial fibrillation and stroke: three new studies, three remaining questions. Arch Int Med 154:1443-1451.
2. American Diabetes Association (1997). New recommendations about the diagnosis and classification of diabetes mellitus. Diabetes Care 20:1138-1195.
3. American Heart Association (2004). Heart Disease and Stroke Statistics - 2004 Update. American Heart Association, Dallas, TX. Available at http://www.americanheart.org.
4. Berlowitz DR, Ash AS, Hickey EC et al. (1998). Inadequate management of blood pressure in a hypertensive population. N Engl J Med 339:1957-1963.
5. Boudoulas H, Mantzouratos D, Sohn YH, Weissler AM (1986). Left ventricular mass and systolic performance in chronic systemic hypertension. Am J Cardiol 57:232-237.
6. Chimowitz MI, Poole RM, Starling MR, Schwaiger M, Gross MD (1997). Frequency and severity of asymptomatic coronary disease in patients with different causes of stroke. Stroke 28:941-945.
7. Collins R, Peto R, MacMahon S et al. (1990). Blood pressure, stroke and coronary heart disease: Part 2. Short-term reductions in blood pressure: overview of randomized drug trials in their epidemiological context. Lancet 335:827-836.
8. Cruickshank JM, Neil-Dwyer G, Dorrance DE, Hayes Y, Patel S (1989). Acute effects of smoking on blood pressure and cerebral blood flow. J Hum Hypertens 3:443-449.
9. D'Agostino RB, Wolf PA, Belanger AJ, Kannel WB (1994). Stroke risk profile: adjustment for antihypertensive medication: the Framingham study. Stroke 25:40-43.
10. Di Pasquale G, Andreoli A, Pinelli G et al. (1986). Cerebral ischemia and asymptomatic coronary artery disease: a prospective study of 83 stroke patients. Stroke 17:1098-1101.
11. Gorelick PB (1995). Stroke prevention. Arch Neurol 52:347-355.
12. Hadjiev DI, Mineva PP, Vukov MI (2003). Multiple modifiable risk factors for first ischemic stroke: a population-based epidemiological study. Eur J Neurol 10:577-582.
13. Hankey GJ (1999). Preventing stroke - what is the real progress? Med J Aus 171:285-286.
14. Hankey G, Warlow C (1999). Treatment and secondary prevention of stroke: evidence, costs and effects on individuals and populations. Lancet 354:1457-1463.
15. Hertzer NR, Young JR, Beven EG et al. (1985). Coronary angiography in 506 patients with extracranial cerebrovascular disease. Arch Int Med 145:849-856.
16. Joint National Committee (1997). The sixth report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. Arch Intern Med 157:2413-2446.
17. Jorgensen HS, Nakayama H, Raaschou HO, Olsen TS (1994). Stroke in patients with diabetes. The Copenhagen stroke study. Stroke 25:1977-1984.
18. Kannel WB, McGee DL (1979). Diabetes and cardiovascular disease: the Framingham study. JAMA 241:2035-2038.
19. Klungel OH, de Boer A, Paes AH, Seidell JC, Nagelkerke NJ, Bakker A (1998). Undertreatment of hypertension in a population-based study in the Netherlands. J Hypertens 16:1371-1378.
20. Klungel OH, Stricker BH, Paes AH et al. (1999). Excess stroke among hypertensive men and women attributable to undertreatment of hypertension. Stroke 30:1312-1318.
21. Kool MJ, Hoeks AP, StruijkerBoudier HA, Reneman RS, VanBortel LM (1993). Short term and long term effects of smoking on arterial wall properties in habitual smokers. J Am Coll Cardiol 22:1881-1886.
22. Ladurner G, Pritz W (1987). Die Prävalenz des Schlaganfalls im Bundesland Salzburg. Nervenarzt 58:19-21.
23. Laupacis A, Albers G, Dalen J, Dunn MI, Jacobson AK, Singer DE (1998). Antithrombotic therapy in atrial fibrillation. Chest 114(Suppl.):579S-589S.
24. MacMahon S, Peto R, Cutler J et al. (1990). Blood pressure, stroke and coronary heart disease, part 1: prolonged differences in blood pressure: prospective observational studies corrected for the regression bias. Lancet 335:765-774.
25. Malmgren R, Bamford J, Warlow C, Sandercock P, Slattery J (1989). Projecting the number of patients with first-ever strokes and patients newly handicapped by stroke in England and Wales. Br Med J 298:656-660.
26. Mosterd A, D'Agostino RB, Silbershatz H et al. (1999). Trends in the prevalence of hypertension, antihypertensive therapy, and left ventricular hypertrophy from 1950 to 1980. N Engl J Med 340:1221-1227.
27. Olesen J, Leonardi M (2003). The burden of brain diseases in Europe. Eur J Neurol 10:471-477.
28. Pharmametrics (1994). Sanofi-Synthelabo Austria. Koppstrasse 116 Vienna.
29. Sacco RL, Benjamin EJ, Broderick JP et al. (1997). American Heart Association Prevention Conference IV: prevention and rehabiltation of stroke: risk factors. Stroke 28:1507-1517.
30. Shinton R, Beevers G (1989). Meta-analysis of relation between cigarette smoking and stroke. BMJ 298:789-794.
31. Thamm M (1999). Blutdruck in Deutschland-Zustandsbeschreibung und Trends. Gesundheitswesen 61(Sonderheft 2):90-93.
32. The Atrial Fibrillation Investigators (1994). Risk factors for stroke and efficiacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized controlled trials. Arch Int Med 154:1449-1457.
33. Thefeld W (1999). Prävalenz des Diabetes mellitus in der erwachsenen Bevölkerung Deutschlands. Gesundheitswesen 61 (Suppl. 2): 85-89.
34. Tuomilehto J, Rastenyte D (1999). Diabetes and glucose intolerance as risk factors for stroke. J Cardiovasc Risk 6:241-249.
35. Uehara T, Tabuchi M, Mori E, Yamadori C (2003). Evolving atherosclerosis at carotid and intracranial arteries in Japanese patients with ischemic heart disease: a 5-year longitudinal study with MR angiography. Eur J Neurol 10:507-512.
36. UK Prospective Diabetes Study Group (1998). Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352:854-865.
37. Van der Velden K, Fleming DM, Abrahamse H (1999). Primary health care. Screening in primary care: health for all? A study in dutch general practice. Eur J Public Health 9:290-293.
38. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Porcellati C (1997). Prognostic significance of the white coat effect. Hypertension 29:1218-1224.
39. Weinehall L, Hallgren CG, Westman G, Janlert U, Wall S (1998). Reduction of selection bias in primary prevention of cardiovascular disease through involvement of primary health care. Scand J Prim Health Care 16:171-176.
40. Wibers DO, Whisnant JP, O'Fallon M (1982). Reversible ischemic neurological deficit (RIND) in a community: Rochester, Minnesota 1955-1969. Neurology 32:459-465.
41. Wolf PA, Dawber TR, Thomas HE, Kannel WB (1978). Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study, Neurology 28:973-977.
42. Wolf PA, Kannel WB, McGee DL, Meeks SL, Bharucha NE, McNamara PM (1983). Duration of atrial fibrillation and imminence of stroke: the Framingham study. Stroke 14:664-670.
43. Wolf PA, D'Agostino RB, Kannel WB, Bonita R, Belanger AJ (1988). Cigarette smoking as risk factor for stroke: the Framingham study. JAMA 259:1025-1029.
44. Wolf PA, D'Agostino RB, Belanger AJ, Kannel WB (1991). Probability of stroke: a risk porofile from the Framingham Study. Stroke 22:312-318.
45. World Health Organisation (WHO) (1999). World Health Report 1999. World Health Organisation, Geneva.